To Give or Not to Give Adjuvant Chemotherapy in Breast Cancer? Can CanAssist Breast Assist? [0.03%]
CanCanAssist Breast在乳腺癌的辅助化疗中怎么说？
Amol Akhade,Aju Mathew
Amol Akhade
Correlation of Nuclear Morphometry with Clinicopathologic Parameters in Malignant Breast Aspirates [0.03%]
恶性乳腺穿刺标本的核形态计量与临床病理参数的相关性研究
Shivani Kalhan,Shilpa Garg,Rahul N Satarkar et al.
Shivani Kalhan et al.
Shilpa GargBackground Nuclear size, shape, chromatin pattern, and nucleolar size and number have all been reported to change in breast cancer. Aim The aim of the study was to quantify nuclear changes on malignant breast aspirates using morp...
Cancer in the Adolescent and Young Adults (AYA) and Children: A Comprehensive Analysis of the Epidemiology and Psychosocial Morbidity in the Indian Population [0.03%]
印度青少年和年輕成人(AYA)及兒童癌症的流行病學和心理社會疾病的全面分析
Bhupesh Guleria,S Viswanath,Dharmesh Soneji et al.
Bhupesh Guleria et al.
Bhupesh GuleriaAims Adolescent and young adults (AYAs), children with cancer, and their guardians have unique psychosocial morbidities adversely effecting quality of life (QOL). This is measurable using patented tools. We analyzed epidemiol...
Study of Gemcitabine Plus Nab-Paclitaxel-Based Chemotherapy Regimen as First-Line Treatment in Metastatic Pancreatic Carcinoma [0.03%]
吉西他滨联合白蛋白结合型紫杉醇新方案作为晚期胰腺癌一线治疗的研究
Kshitij Domadia,Varun Goel,Venkata Pradeep Babu Koyyala et al.
Kshitij Domadia et al.
Varun GoelBackground The purpose of this study was to study the effectiveness of gemcitabine and nab-paclitaxel combination as first-line chemotherapy regimen for the treatment of metastatic pancreatic cancer. There is scarcity of data rega...
Treatment Outcomes of Advanced Cholangiocarcinoma: A Single-Center Experience from India [0.03%]
晚期胆管癌的治疗结果：印度单中心经验
Niranjan Vijayaraghavan,Rakesh Mp,Latha Kvs
Niranjan Vijayaraghavan
Niranjan VijayaraghavanBackground Survival data for patients with advanced cholangiocarcinoma are very sparse in India. We performed this study to find the median overall survival of patients with advanced cholangiocarcinoma and to identify...
Development of a New Tool to Assess the Quality of Life of Patients with Hand-Foot Syndrome Receiving Capecitabine-Based Therapy: A Pilot Study [0.03%]
开普拓治疗手足综合征患者生活质量评估新工具的开发：一项试点研究
Prathepa Jagdish,Navdeep Kaur,Akhil Kapoor et al.
Prathepa Jagdish et al.
Prathepa JagdishBackground Hand-foot syndrome (HFS) can result in significant deficits in health-related quality of life (HRQOL) and can lead to poor compliance, dose reduction, or interruption. This study was performed to assess the HRQOL ...
Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis [0.03%]
高_grade B_细胞淋巴瘤的治疗结局：回顾性分析
Parathan Karunakaran,Gangothri Selvarajan,Jayachandran Perumal Kalaiyarasi et al.
Parathan Karunakaran et al.
The nomenclature high-grade non-Hodgkin's lymphoma was repurposed in the World Health Organization (WHO) 2016 update as high-grade B cell lymphoma (HGBL). However, among the HGBL entities HGBL, not otherwise specified (NOS) remains a poorly...
Oral Tegafur-Uracil Combination plus Leucovorin versus Other Fluoropyrimidine Agents in Colorectal Cancer: A Systematic Review and Meta-Analysis [0.03%]
替加氟尿嘧啶口服组合与亚叶酸联合其他氟尿嘧啶类药物治疗结直肠癌：系统性回顾和meta分析
Satya Pal Kataria,Mukesh Nagar,Shikha Verma et al.
Satya Pal Kataria et al.
Shikha VermaBackground Systemic fluoropyrimidines, both oral and intravenous, are an integral part of colorectal cancer (CRC) management. They can be administered either with curative or palliative intent. Objectives This article examines t...
Ramucirumab in Indian Patients with Advanced Gastric Cancer-Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit? [0.03%]
关于乐伐替尼在印度晚期胃癌患者中的应用：现实生活实践中的边缘体能状态和沉重的疾病负担是否会影响临床获益？
Anant Ramaswamy,Kripa Bajaj,Vineet Talwar et al.
Anant Ramaswamy et al.
Vikas OstwalBackground Ramucirumab is considered a standard of care as second-line therapy (CT2) in advanced gastric cancers (AGCs). The aim of this study was to assess practice patterns and outcomes with ramucirumab among Indian patients w...
Evaluating the Effect of Health Education Intervention on the Health Beliefs and Behaviors of First-Degree Female Relatives of Breast Cancer Patients [0.03%]
乳腺癌患者一级女性亲属健康教育干预效果评价研究
Sule Olgun,Berna Dizer
Sule Olgun
Sule OlgunBackground Breast cancer risk increases by 80% in the presence of BRCA1 and BRCA2 gene mutations in the same family. In particular, a woman whose sister or mother has breast cancer has a 2- to 5-fold higher risk of developing brea...